Chen, S., Sun, Q., Cao, L., Wu, W., Xie, Y., Qiao, C., . . . Hong, M. (2021). Efficacy and safety of decitabine combined with low-dose cytarabine, aclarubicin, and granulocyte colony-stimulating factor compared with standard therapy in acute myeloid leukemia patients with TP53 mutation. Chin Med J (Engl).
Citação norma ChicagoChen, Si-Si, Qian Sun, Lan Cao, Wen-Zhong Wu, Yue Xie, Chun Qiao, Jian-Yong Li, Si-Xuan Qian, and Ming Hong. "Efficacy and Safety of Decitabine Combined With Low-dose Cytarabine, Aclarubicin, and Granulocyte Colony-stimulating Factor Compared With Standard Therapy in Acute Myeloid Leukemia Patients With TP53 Mutation." Chin Med J (Engl) 2021.
Citação norma MLAChen, Si-Si, et al. "Efficacy and Safety of Decitabine Combined With Low-dose Cytarabine, Aclarubicin, and Granulocyte Colony-stimulating Factor Compared With Standard Therapy in Acute Myeloid Leukemia Patients With TP53 Mutation." Chin Med J (Engl) 2021.